Anyone curious on who Otsuka is looking to buy with all that new money from selling shares. My guess is a small company that is not to expensive with a new product that the larger companies wouldn't notice. Question is do they match it to Nueroscience or move to make the Hospital division profitable. I guess bolster the Hospital team because right now 90 reps selling samsca is just breaking even. Barons had a nice article with large and small pharma companies as take over bids. I see a handful that meet Otsuka needs. Brondo could be back.
